Dear PSL members,

NASDAQ stocks with negative closings: (AEZD, EXEL, CPST, LXRX, KERX)

AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) reported the fall of 0.89% and closed at $1.11. It touched the day high of $1.05 with overall traded volume of 1.42 million shares. AEterna Zentaris Inc. is a drug development company specialized in oncology and endocrine therapy.

Exelixis, Inc. (NASDAQ: EXEL) touched the low of $3.1 to close at $3.11. After dropping by 10.12% whereas total traded volume stood at 1.41 million shares for the day. Exelixis, Inc. (Exelixis) is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.

Capstone Turbine Corporation (NASDAQ: CPST) plunged by 3.29% and touched its day high of $0.97. It closed on $0.92 with traded volume of 1.33 million shares in the last trading session. Capstone Turbine Corporation (Capstone) develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications, including cogeneration (combined heat and power (CHP), integrated combined heat and power (ICHP), and combined cooling, heat and power (CCHP)), resource recovery and secure power. In addition, its microturbines can be used as battery charging generators for hybrid electric vehicle applications.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) witnessed the correction of 8.2% to close at $1.23. It touched the day high of $1.36 whereas overall traded volume stood at 1.32 million shares for the day. Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company focused on the discovery and development of treatments for human disease.

Keryx Biopharmaceuticals (NASDAQ: KERX) touched the low of $3.63 and closed at $3.70. It reported the fall of 7.04% with total traded volume of 1.30 million shares. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.

***********************

Limited Time Offer:

• We are offering only 200 more spots to join our Premium Subscribers Listfor only $9.99 per month for a lifetime guarantee on that price.
• So what happens to the 201st premium subscriber and thereafter, you will be paying $49.99 per month.
• We have been in long discussions and we have decided to raise our rates on our subscribers that apply to our list after the 200th person.
• For those of you who are our current subscribers and the next 200 subscribers…will keep their price of $9.99 for a lifetime guarantee. We are not raising rates for you.
• The reason we have decided to raise our rates to $49.99 is due to the growing demand in our services, and the overall great success that we have achieved with almost all of our picks.

Click HERE to subscribe through PayPal for $9.99 a month for next 200 subscribers…

************************

Happy trading,

PSL staff, www.PennyStockLive.com